← Leaderboards
Helen H Lee
Diagnostics For The Real World, Ltd
$18,767,046
Attributed
$19,723,183
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$19,224,326 · 14
CDC$498,857 · 1
By mechanism
R44$14,011,308 · 6
SB1$2,730,147 · 1
R61$1,247,132 · 1
R43$1,235,739 · 6
U01$498,857 · 1
Top collaborators
- Cesar Nadala3 shared
- Oche Ochai Agbaji1 shared
- Phyllis J. Kanki1 shared
Others in their field
Top investigators on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- David R. Weir · University Of Michigan At Ann Arbor$380,905,171
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- David Heimbrook · Leidos Biomedical Research, Inc.$223,969,650
- Ralph Parchment · Leidos Biomedical Research, Inc.$159,723,588
- Barbara Driver · Westat, Inc.$149,946,903
Research focus
DiagnosticSamplingDiagnostic TestsWhole BloodResourcesPerformanceSmall Business Innovation Research GrantBlood BanksEuropeViral Load ResultClinical ResearchCountryEvaluationPoint Of CareReagentBaseDesignInfectionMonitorHuman Immunodeficiency Virus TestDiagnosis Design /EvaluationDetectionHiv-1Blood Bank /Supply Contamination
Grant awards (35)
Feasibility and development of an automated HIV self-testing system$411,509
R61 · FY2021 · AI · contact PI
Feasibility and development of an automated HIV self-testing system$416,646
R61 · FY2020 · AI · contact PI
Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings$836,175
SB1 · FY2019 · AI · contact PI
Feasibility and development of an automated HIV self-testing system$418,977
R61 · FY2019 · AI · contact PI
Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings$986,095
SB1 · FY2018 · AI · contact PI
Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings$390,846
R44 · FY2018 · AI · contact PI
Development of a simple and robust point-of-care test for detection of Hepatitis C RNA from finger prick whole blood in resource-limited settings$143,627
R43 · FY2018 · AI · contact PI
Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings$968,003
R44 · FY2017 · AI · contact PI
Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings$907,877
SB1 · FY2017 · AI · contact PI
SAMBA HIV-1 Semi-quantitative whole blood test for resource limited settings$951,508
R44 · FY2016 · AI · contact PI
Reaching 90% target of HIV viral suppression: The role of point of care VL monitoring in resources constrained settings$498,857
U01 · FY2016 · GH
SAMBA HIV-1 Semi-quantitative Test for resource limited settings$617,625
R44 · FY2015 · AI · contact PI
SAMBA HIV-1 Semi-quantitative Test for resource limited settings$747,488
R44 · FY2014 · AI · contact PI
SAMBA HIV-1 Semi-quantitative Test for resource limited settings$276,127
R43 · FY2012 · AI · contact PI
DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval$836,222
R44 · FY2011 · HL · contact PI
SAMBA HIV-1 Semi-quantitative Test for resource limited settings$300,000
R43 · FY2011 · AI · contact PI
DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval$1,075,162
R44 · FY2010 · HL · contact PI
DRW HIV-Ab/HBsAg Duplex Rapid Test submission for FDA-PMA approval$19,800
R44 · FY2009 · HL · contact PI
DRW HIV-Ab/HBsAg Duplex Rapid Test submission for FDA-PMA approval$1,762,981
R44 · FY2008 · HL · contact PI
Preclinical and clinical studies of an HBV rapid test for FDA Pre-market approval$964,487
R44 · FY2007 · HL · contact PI
Triplex HBV, HCV an HIV dipstick for blood banks$575,660
R44 · FY2007 · HL · contact PI
Triplex HBV, HCV an HIV dipstick for blood banks$441,494
R44 · FY2006 · HL · contact PI
HCV dipstick for resource-limited blood banks$358,153
R44 · FY2006 · HL · contact PI
Triplex HBV, HCV an HIV dipstick for blood banks$402,468
R44 · FY2005 · HL
HCV dipstick for resource-limited blood banks$330,591
R44 · FY2005 · HL
HIV dipstick for resource-limited blood banks$1,129,489
R44 · FY2004 · HL
HIV dipstick for resource-limited blood banks$559,961
R44 · FY2004 · HL
HBV dipstick for resource-limited blood banks$388,206
R44 · FY2004 · HL
HBV dipstick for resource-limited blood banks$350,000
R44 · FY2004 · HL
HIV dipstick for resource-limited blood banks$582,601
R44 · FY2003 · HL
HBV dipstick for resource-limited blood banks$558,563
R44 · FY2003 · HL
Triplex HIV, HCV and HBV dipstick$134,520
R43 · FY2003 · HL
HCV dipstick for resource-limited blood banks$127,155
R43 · FY2002 · HL
HIV dipstick for resoruce-limited blood banks$127,155
R43 · FY2002 · HL
HBV dipstick for resource-limited blood banks$127,155
R43 · FY2002 · HL